BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maor-kendler Y, Batts KP, Burgart LJ, Wiesner RH, Krom RA, Rosen CB, Charlton MR. COMPARATIVE ALLOGRAFT HISTOLOGY AFTER LIVER TRANSPLANTATION FOR CRYPTOGENIC CIRRHOSIS, ALCOHOL, HEPATITIS C, AND CHOLESTATIC LIVER DISEASES1: . Transplantation 2000;70:292-7. [DOI: 10.1097/00007890-200007270-00009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Demetris AJ; Banff Working Group. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006;44:489-501. [DOI: 10.1002/hep.21280] [Cited by in Crossref: 256] [Cited by in F6Publishing: 194] [Article Influence: 16.0] [Reference Citation Analysis]
2 Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, Khettry U. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol. 2002;33:1098-1104. [PMID: 12454814 DOI: 10.1053/hupa.2002.129419] [Cited by in Crossref: 116] [Cited by in F6Publishing: 89] [Article Influence: 5.8] [Reference Citation Analysis]
3 Dureja P, Mellinger J, Agni R, Chang F, Avey G, Lucey M, Said A. NAFLD recurrence in liver transplant recipients. Transplantation. 2011;91:684-689. [PMID: 21248661 DOI: 10.1097/tp.0b013e31820b6b84] [Cited by in Crossref: 105] [Cited by in F6Publishing: 31] [Article Influence: 9.5] [Reference Citation Analysis]
4 Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141:1249-1253. [PMID: 21726509 DOI: 10.1053/j.gastro.2011.06.061] [Cited by in Crossref: 770] [Cited by in F6Publishing: 688] [Article Influence: 70.0] [Reference Citation Analysis]
5 Álamo JM, Bernal C, Barrera L, Marín LM, Suárez G, Serrano J, Gómez MA, Padillo FJ. Liver transplantation in patients with cryptogenic cirrhosis: long-term follow-up. Transplant Proc. 2011;43:2230-2232. [PMID: 21839241 DOI: 10.1016/j.transproceed.2011.05.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dutkowski P, Linecker M, Deoliveira ML, Müllhaupt B, Clavien P. Challenges to Liver Transplantation and Strategies to Improve Outcomes. Gastroenterology 2015;148:307-23. [DOI: 10.1053/j.gastro.2014.08.045] [Cited by in Crossref: 135] [Cited by in F6Publishing: 134] [Article Influence: 19.3] [Reference Citation Analysis]
7 Berg T, Neuhaus R, Klein R, Leder K, Lobeck H, Bechstein W, Müller AR, Wiedenmann B, Hopf U, Berg PA, Neuhaus P. DISTINCT ENZYME PROFILES IN PATIENTS WITH CRYPTOGENIC CIRRHOSIS REFLECT HETEROGENEOUS CAUSES WITH DIFFERENT OUTCOMES AFTER LIVER TRANSPLANTATION (OLT): A LONG-TERM DOCUMENTATION BEFORE AND AFTER OLT: . Transplantation 2002;74:792-8. [DOI: 10.1097/00007890-200209270-00010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
8 Charlton M. Obesity, hyperlipidemia, and metabolic syndrome. Liver Transpl. 2009;15 Suppl 2:S83-S89. [PMID: 19877024 DOI: 10.1002/lt.21914] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
9 Bernal-Reyes R, Castro-Narro G, Malé-Velázquez R, Carmona-Sánchez R, González-Huezo MS, García-Juárez I, Chávez-Tapia N, Aguilar-Salinas C, Aiza-Haddad I, Ballesteros-Amozurrutia MA, Bosques-Padilla F, Castillo-Barradas M, Chávez-Barrera JA, Cisneros-Garza L, Flores-Calderón J, García-Compeán D, Gutiérrez-Grobe Y, Higuera de la Tijera MF, Kershenobich-Stalnikowitz D, Ladrón de Guevara-Cetina L, Lizardi-Cervera J, López-Cossio JA, Martínez-Vázquez S, Márquez-Guillén E, Méndez-Sánchez N, Moreno-Alcantar R, Poo-Ramírez JL, Ramos-Martínez P, Rodríguez-Hernández H, Sánchez-Ávila JF, Stoopen-Rometti M, Torre-Delgadillo A, Torres-Villalobos G, Trejo-Estrada R, Uribe-Esquivel M, Velarde-Ruiz Velasco JA. The Mexican consensus on nonalcoholic fatty liver disease.Rev Gastroenterol Mex (Engl Ed). 2019;84:69-99. [PMID: 30711302 DOI: 10.1016/j.rgmx.2018.11.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Sourianarayanane A, Arikapudi S, McCullough AJ, Humar A. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation. Eur J Gastroenterol Hepatol. 2017;29:481-487. [PMID: 28253211 DOI: 10.1097/meg.0000000000000820] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 3.4] [Reference Citation Analysis]
11 Sutedja DS, Gow PJ, Hubscher SG, Elias E. Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy. Transplant Proc. 2004;36:2334-2337. [PMID: 15561241 DOI: 10.1016/j.transproceed.2004.07.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
12 Ekong UD, Melin-Aldana H, Seshadri R, Lokar J, Harris D, Whitington PF, Alonso EM. Graft histology characteristics in long-term survivors of pediatric liver transplantation. Liver Transpl. 2008;14:1582-1587. [PMID: 18975292 DOI: 10.1002/lt.21549] [Cited by in Crossref: 102] [Cited by in F6Publishing: 76] [Article Influence: 7.8] [Reference Citation Analysis]
13 Cotter TG, Charlton M. Nonalcoholic Steatohepatitis After Liver Transplantation. Liver Transpl 2019;26:141-59. [DOI: 10.1002/lt.25657] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
14 Neil DA, Hübscher SG. Current views on rejection pathology in liver transplantation. Transpl Int. 2010;23:971-983. [PMID: 20723179 DOI: 10.1111/j.1432-2277.2010.01143.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 8.4] [Reference Citation Analysis]
15 Brunt EM, Tiniakos DG. Steatosis, steatohepatitis: Review of effects on chronic hepatitis C. Current Hepatitis Reports 2002;1:38-44. [DOI: 10.1007/s11901-002-0007-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
16 Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36:227-242. [PMID: 12085369 DOI: 10.1053/jhep.2002.34734] [Cited by in Crossref: 406] [Cited by in F6Publishing: 368] [Article Influence: 20.3] [Reference Citation Analysis]
17 Pelletier SJ, Schaubel DE, Punch JD, Wolfe RA, Port FK, Merion RM. Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl. 2005;11:434-440. [PMID: 15776460 DOI: 10.1002/lt.20342] [Cited by in Crossref: 67] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
18 Koehler E, Watt K, Charlton M. Fatty Liver and Liver Transplantation. Clinics in Liver Disease 2009;13:621-30. [DOI: 10.1016/j.cld.2009.07.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
19 Steggerda JA, Mahendraraj K, Todo T, Noureddin M. Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge. World J Gastroenterol 2020; 26(28): 4018-4035 [PMID: 32821068 DOI: 10.3748/wjg.v26.i28.4018] [Reference Citation Analysis]
20 Malhi H, Allen AM, Watt KD. Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival. Curr Opin Organ Transplant. 2016;21:99-106. [PMID: 26825357 DOI: 10.1097/mot.0000000000000283] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
21 Lucey MR. Serial liver biopsies: a gateway into understanding the long-term health of the liver allograft. J Hepatol. 2001;34:762-763. [PMID: 11434625 DOI: 10.1016/s0168-8278(01)00070-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
22 Wong RJ, Ahmed A. Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations. World J Hepatol 2014; 6(5): 263-273 [PMID: 24868320 DOI: 10.4254/wjh.v6.i5.263] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 9.6] [Reference Citation Analysis]
23 Mandal S, Miraglia R, Maruzzelli L, Liotta R, Tuzzolino F, Spada M, Riva S, Luca A. US-guided percutaneous liver biopsy in pediatric liver transplant recipients. J Pediatr Gastroenterol Nutr 2014;58:756-61. [PMID: 24509302 DOI: 10.1097/MPG.0000000000000328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
24 Shaker M, Tabbaa A, Albeldawi M, Alkhouri N. Liver transplantation for nonalcoholic fatty liver disease: New challenges and new opportunities. World J Gastroenterol 2014; 20(18): 5320-5330 [PMID: 24833862 DOI: 10.3748/wjg.v20.i18.5320] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 56] [Article Influence: 7.6] [Reference Citation Analysis]
25 Sutedja DS, Gow PJ, Hubscher SG, Elias E. Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy. Transplant Proc. 2004;36:2334-2337. [PMID: 15561241 DOI: http: //dx.doi.orq/10.1016/j.transproceed.2004.07.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Khullar V, Dolganiuc A, Firpi RJ. Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease. World J Transplant 2014; 4(2): 81-92 [PMID: 25032097 DOI: 10.5500/wjt.v4.i2.81] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
27 Charlton M. Evolving aspects of liver transplantation for nonalcoholic steatohepatitis. Curr Opin Organ Transplant. 2013;18:251-258. [PMID: 23652610 DOI: 10.1097/mot.0b013e3283615d30] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 4.1] [Reference Citation Analysis]
28 Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16(42): 5286-5296 [PMID: 21072891 DOI: 10.3748/wjg.v16.i42.5286] [Cited by in CrossRef: 230] [Cited by in F6Publishing: 210] [Article Influence: 19.2] [Reference Citation Analysis]
29 Hernandez-Alejandro R, Croome KP, Drage M, Sela N, Parfitt J, Chandok N, Marotta P, Dale C, Wall W, Quan D. A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma. World J Gastroenterol 2012; 18(31): 4145-4149 [PMID: 22919246 DOI: 10.3748/wjg.v18.i31.4145] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
30 Mells G, Mann C, Hubscher S, Neuberger J. Late protocol liver biopsies in the liver allograft: a neglected investigation? Liver Transpl. 2009;15:931-938. [PMID: 19642126 DOI: 10.1002/lt.21781] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
31 Cuschieri JR, John BK, Miick R, Ortiz JA, Hashemi N. Successful Treatment of Rapid Onset, Symptomatic de novo Non-alcoholic Steatohepatitis Following Liver Transplantation: A Case Report. J Clin Exp Hepatol 2013;3:70-4. [PMID: 25755474 DOI: 10.1016/j.jceh.2013.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Ong J, Younossi ZM. Non-Alcoholic Fatty Liver Disease After Liver Transplantation: A Case of Nurture and Nature. American Journal of Gastroenterology 2010;105:621-3. [DOI: 10.1038/ajg.2009.720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
33 Singal AK, Charlton M. Transplantation for Nonalcoholic Steatohepatitis. Transplantation of the Liver. Elsevier; 2015. pp. 250-5. [DOI: 10.1016/b978-1-4557-0268-8.00022-1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328-357. [PMID: 28714183 DOI: 10.1002/hep.29367] [Cited by in Crossref: 1978] [Cited by in F6Publishing: 1822] [Article Influence: 395.6] [Reference Citation Analysis]
35 Heneghan MA, Zolfino T, Muiesan P, Portmann BC, Rela M, Heaton ND, O'grady JG. An evaluation of long-term outcomes after liver transplantation for cryptogenic cirrhosis. Liver Transpl. 2003;9:921-928. [PMID: 12942453 DOI: 10.1053/jlts.2003.50165] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
36 Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology. 2014;59:2188-2195. [PMID: 24375711 DOI: 10.1002/hep.26986] [Cited by in Crossref: 437] [Cited by in F6Publishing: 394] [Article Influence: 54.6] [Reference Citation Analysis]
37 Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Liver Transpl. 2012;18:1154-1170. [PMID: 22645090 DOI: 10.1002/lt.23481] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 8.7] [Reference Citation Analysis]
38 Pham T, Dick TB, Charlton MR. Nonalcoholic Fatty Liver Disease and Liver Transplantation. Clin Liver Dis 2016;20:403-17. [PMID: 27063277 DOI: 10.1016/j.cld.2015.10.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
39 Shaikh OS, Demetris AJ. Idiopathic posttransplantation hepatitis? Liver Transpl. 2007;13:943-946. [PMID: 17600346 DOI: 10.1002/lt.21202] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
40 Cholankeril G, Wong RJ, Hu M, Perumpail RB, Yoo ER, Puri P, Younossi ZM, Harrison SA, Ahmed A. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. Dig Dis Sci. 2017;62:2915-2922. [PMID: 28744836 DOI: 10.1007/s10620-017-4684-x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 110] [Article Influence: 22.6] [Reference Citation Analysis]
41 Satapathy SK, Nair S, Vanatta JM. Nonalcoholic fatty liver disease following liver transplantation. Hepatol Int 2013;7:400-12. [PMID: 26201774 DOI: 10.1007/s12072-013-9434-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
42 Neff G, Shire N, Ruiz P, O’brien C, Garcia M, dela Garza J, Rudich S, Reddy KR. The Importance of Clinical Parameters When Differentiating Cholestatic Hepatitis C Virus From Allograft Rejection. Transplantation Proceedings 2005;37:4397-402. [DOI: 10.1016/j.transproceed.2005.10.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
43 Kutsenko A, Ladenheim MR, Kim N, Nguyen P, Chen V, Jayasekera C, Yang JD, Kumari R, Roberts L, Nguyen MH. Increased Prevalence of Metabolic Risk Factors in Asian Americans With Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 2017;51:384-90. [DOI: 10.1097/mcg.0000000000000689] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
44 El-Masry M, Puig CA, Saab S. Recurrence of non-viral liver disease after orthotopic liver transplantation. Liver Int. 2011;31:291-302. [PMID: 21281429 DOI: 10.1111/j.1478-3231.2010.02434.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
45 Perumpail RB, Hahambis TA, Aggarwal A, Younossi ZM, Ahmed A. Treatment strategies for chronic hepatitis C prior to and following liver transplantation. World J Hepatol 2016; 8(1): 69-73 [PMID: 26783422 DOI: 10.4254/wjh.v8.i1.69] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
46 Ekong UD. The long-term liver graft and protocol biopsy: do we want to look? What will we find? Current Opinion in Organ Transplantation 2011;16:505-8. [DOI: 10.1097/mot.0b013e32834a8caf] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
47 Ahmed A, Keeffe EB. Hepatitis C virus and liver transplantation. Clin Liver Dis. 2001;5:1073-1090. [PMID: 11685796 DOI: 10.1016/s1089-3261(05)70210-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
48 Demetris A, Crawford JM, Minervini MI, Nalesnik M, Ochoa E, Randhawa P, Sasatomi E, Wu T. Transplantation Pathology of the Liver. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 1169-229. [DOI: 10.1016/b978-141604059-0.50047-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
49 Targhetta S, Villamil F, Inturri P, Pontisso P, Fagiuoli S, Cillo U, Cecchetto A, Gianni S, Naccarato R, Burra P. Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease. World J Gastroenterol 2006; 12(11): 1706-1712 [PMID: 16586538 DOI: 10.3748/wjg.v12.i11.1706] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]